Skip to content
HeyJared

Kate Hardey

Reporter · US

Indexed articles, last 90 days
3
Latest publication
Aug 3, 2026
Outlet visibility, for Mondaq
Top 500K sites
Earliest in this view
Jul 14, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 3, 2026 · Kate Hardey

    FDA Advisory Committee Recommends Six Peptides For Compounding: What The Evaluation Criteria Tell Us About The Road Ahead (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    On July 23 and 24, the Food and Drug Administration’s (FDA) Pharmacy Compounding Advisory Committee (PCAC or Committee) convened for a closely watched two-day meeting to evaluate whether seven peptides should be recommended for inclusion on the list of bulk drug substances that may be used in compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act (503A Bulks List). The peptides were reviewed in both free base and acetate salt forms. Despite FDA’s scientific review team’s oppo

  2. Article · Jul 20, 2026 · Kate Hardey

    Drawing The Device Line: FDA Seeks Public Input On Patient Safety And Non-Device Health Software (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    On July 14, the U.S. Food and Drug Administration (FDA) announced it is seeking public input regarding the patient safety impacts of certain medical software functions excluded from the definition of a medical device under the 21st Century Cures Act. In particular, the FDA is requesting input on best practices to promote patient safety, education, and competency associated with these non-device software functions. Comments are due August 13, 2026. The statutory definition of a medical device und

  3. Article · Jul 14, 2026 · Kate Hardey

    FDA Proposes New Drug Manufacturing Rule: What Distributed Manufacturing And Foreign API Registration Changes Could Mean For Pharma Compliance (opens the original)

    Excerpt · English

    Read excerpt

    In the wake of the Food & Drug Administration’s (FDA) ambitious unified agenda, on July 13, 2026, the agency published a proposed rule aiming to align its regulatory frameworks with “how distributed manufacturing actually works.” The proposed rule would create a tailored drug establishment registration framework for certain distributed manufacturing establishments (DMEs) and clarify the registration and listing obligations applicable to certain foreign drug establishments. The proposed rule is i

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For Mondaq, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Kate Hardey